Interesting that VOR sprinted up towards a market cap roughly equal to ICG's and then pulled back a bit. Of course they have nothing in common apart from the porphyry style findings, but it could be a case of one's performance having an affect on the other over the coming week. No other reason for it than simple market psychology. Right now the market seems to be happy to value them both at $30M but that could soon change.
